NCT04477499 is a clinical trial in Ventricular Tachycardia (V-Tach), sponsored by The Cleveland Clinic.

Who is sponsoring NCT04477499?

NCT04477499 is sponsored by The Cleveland Clinic.

What condition does NCT04477499 study?

NCT04477499 studies Ventricular Tachycardia (V-Tach), Implantable Cardioverter Defibrillator (ICD), Arrythmia.

Is NCT04477499 still recruiting?

NCT04477499 is currently completed. Last updated 10 January 2023.

Last reviewed 2023-01-10 · How we verify

NCT04477499

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Parallel Mapping for Ventricular Tachycardia

Completed Last updated 10 January 2023

What this trial tests

trial in Ventricular Tachycardia (V-Tach) in 44 participants. Completed in 30 December 2022.

Timeline

15 July 2020

Primary endpoint
30 December 2022

30 December 2022

Quick facts

Lead sponsor	The Cleveland Clinic
Status	Completed
Study type	OBSERVATIONAL
Enrollment	44
Start date	15 July 2020
Primary completion	30 December 2022
Estimated completion	30 December 2022
Sites	1 location across United States

Conditions studied

Ventricular Tachycardia (V-Tach) — all drugs for Ventricular Tachycardia (V-Tach) →
Implantable Cardioverter Defibrillator (ICD) — all drugs for Implantable Cardioverter Defibrillator (ICD) →
Arrythmia — all drugs for Arrythmia →

Sponsor

The Cleveland Clinic

Who can join

18 and older, any sex, with Ventricular Tachycardia (V-Tach) or Implantable Cardioverter Defibrillator (ICD). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Catheter ablation in patients with ventricular tachycardia using a new mapping algorithm called, parallel mapping, that is aimed to increase the specificity of mapping and the outcome of ablation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other The Cleveland Clinic trials

Trials by the same sponsor.

NCT07218198 — Clinical Decision Support Tool for the Treatment of Uncontrolled Hypertension · NA · not yet recruiting
NCT07442747 — Neural Mechanisms of Aerobic Exercise Benefits in PD With DBS · NA · not yet recruiting
NCT07471464 — Centered Surgery - Preoperative Counseling and Patient Satisfaction · recruiting
NCT07073963 — Virtual Patient Groups for Sarcoidosis Associated Fatigue · NA · recruiting
NCT07363343 — Nifedipine and Enalapril vs Nifedipine and Labetalol for the Treatment of Postpartum Hypertension Study · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04477499 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The Cleveland Clinic
Last refreshed: 10 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04477499.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing